Becton Dickinson (NYSE:BDX) announced today that it is collaborating with Scanwell Health to create an at-home rapid COVID-19 test. Scanwell Health, a developer of smartphone-enabled at-home medical tests, will offer its mobile app to pair with a BD antigen test for SARS-CoV-2, the virus causing COVID-19, according to a news release. As part of the collaboration, […]
becton dickinson
BD wins Frost & Sullivan innovation award for Intevia autoinjector
Frost & Sullivan announced today that it recognizes Becton Dickinson (NYSE:BDX) with a 2020 Global Technology Innovation Award. BD received the award for its Intevia autoinjector, which, as part of the company’s differentiated self-injection systems portfolio, facilitates high-viscosity biologics delivery for treating chronic diseases, according to a news release. Get the full story at our sister site, […]
BD secures EUA, CE Mark for molecular test for both COVID-19 and flu
BD today said it received FDA emergency use authorization and CE mar approval for its rapid molecular diagnostic test for both SARS-CoV-2 and Influenza A+B test. The test can return results in two to three hours and the FDA EUA includes updated information in the test’s instructions for use that addresses variants of the SARS-CoV-2 […]
MedTech 100 roundup: Index hits another all-time high
The beginning of February brought yet another peak for medtech stocks. MassDevice‘s MedTech 100 index ended the week (Feb. 5) at 108.23 points, marking a 4% rise from the 104.05-point mark set at the end of the previous week (Jan. 29). The final mark for the week sets an all-time best for the index, which had […]
Becton Dickinson beats The Street, raises 2021 guidance
Becton Dickinson (NYSE:BDX) shares dipped slightly despite first-quarter results that came in well above the consensus forecast. The Franklin Lakes, N.J.-based company posted profits of $981 million, or $3.35 per share, on sales of $5.3 billion for the three months ended Dec. 31, 2020, tripling its bottom-line on sales growth of 25.8%. Adjusted to exclude one-time […]
BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
Becton Dickinson (NYSE:BDX) is touting the results of a small, in-house study of its Veritor Plus antigen test over molecular (PCR) tests to indicate whether an infected person is more likely able to spread SARS-CoV-2. The peer-reviewed study compared antigen and PCR test results to positive results using a viral cell culture test. Viral growth […]
BD CEO Polen to also serve as board chair
Tom Polen, the CEO of Becton Dickinson (NYSE:BDX), will also serve as BD’s board chair effective April 28, the company said today. Polen takes over the board chair slot from former CEO Vincent A. Forlenza, who will retire at that time. Polen, 47, has held the corner office at BD since January 2020. He joined […]
Biden’s COVID-19 response will make manufacturers busy
Manufacturers of vaccine supplies and personal protective equipment can expect more work as the new Biden administration rolls out its plans to combat the COVID-19 pandemic. In one of his first official acts as president, Joe Biden announced a plan to “fully use” the Defense Production Act to ramp up production of testing supplies, masks, […]
MedTech 100 roundup: Finally a dip as industry stays relatively strong
After three consecutive weeks of record-breaking numbers, medtech industry stocks finally fell backward over the past seven days. MassDevice‘s MedTech 100 index finished last week at 105.8 (Jan. 15), marking a -0.95% drop from the 106.81 points (the highest ever total for the index) registered at the end of the week prior (Jan. 8). Medtech’s […]
BD stock up on Street-beating preliminary quarterly revenue numbers
Becton Dickinson (NYSE:BDX) today announced that it brought in $5.3 billion in revenue for its first quarter ended Dec. 31, 2020, beating the nearly $4.7 billion expected by Wall Street analysts. The announcement of the preliminary unaudited Q1 results sent BDX shares up 1.8% to $261.75 apiece by midday trading today. MassDevice’s MedTech 100 Index, which includes […]
Medtech takes a stand on D.C. rioting
The medtech industry has joined other business and industry groups in condemning Tuesday’s siege of the Capitol in Washington, D.C. by supporters of President Donald Trump. The National Manufacturers Association called for Vice President Mike Pence to invoke the 25th Amendment to remove President Donald Trump from office. The Business Roundtable tweeted a call for an end […]
